Results 191 to 200 of about 4,458,570 (286)

Particulate matter increases bone morphogenetic protein 2 in lung fibroblasts. [PDF]

Am J Physiol Lung Cell Mol Physiol
Craig N, Berens JP, Boateng E, Scruggs AM, Khater JJ, Chen Y, Deng F, Huang SK.   +7 more
europepmc   +1 more source

Platelet concentrates in sinus augmentation: The impact of platelet dose and biological characteristics—A systematic review and meta‐analysis

European Journal of Oral Sciences, EarlyView.
Abstract This systematic review investigated the osteogenic effects of platelet concentrate (PRF/PRP) when combined with non‐autogenous graft materials in sinus lift procedures. Key characteristics assessed included platelet concentration, total platelet dose, leukocyte content, and fibrin‐network structure.
Olav Kansgar Straum, Hans Thomas Brox, Juliane Hesse, Andreas Jörn Schmalfuss, Erlend Bugge   +4 more
wiley   +1 more source

Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction]. [PDF]

Cancer Manag Res
europepmc   +1 more source

Bone Morphogenetic Protein [PDF]

, 2011
openaire   +1 more source

Treatment approaches for equine subchondral lucencies: Clinical considerations and therapeutic decision‐making

Equine Veterinary Education, EarlyView.
Summary Subchondral lucencies, also referred to as subchondral cystic lesions or osseous cyst‐like lesions, are radiographically identifiable defects of subchondral bone that remain an important cause of lameness and reduced athletic performance in horses.
C. Salazar‐Latorre, R. Salcedo‐Jiménez, M. Masri‐Daba   +2 more
wiley   +1 more source

<i>In vitro</i> chondrogenesis of rat adipose-derived stem cells combined with sodium alginate hydrogel scaffold induced by cartilage-derived morphogenetic protein-1. [PDF]

Front Bioeng Biotechnol
Huang C, Xu N, Zhang L, Zheng K, Zhang W, Zhuo S, Li J, Wang X, Lu S, Lin J.   +9 more
europepmc   +1 more source

Mechanisms underpinning the progression of nondysplastic Barrett's oesophagus to cancer

The FEBS Journal, EarlyView.
Barrett's oesophagus confers a low but significant cancer risk. The condition is common but we do not have effective biomarkers to identify susceptible patients. We believe that there is no single factor that determines cancer risk and an understanding of the combinations of interactions (via gene expression and natural selection) between the Barrett's
Yannick H. Derwa, Meng‐Lay Lin, Stuart A. C. McDonald   +2 more
wiley   +1 more source

The concern on clinical use of recombinant human bone morphogenetic protein-2

Journal of Craniovertebral Junction and Spine, 2011
Viroj Wiwanitkit
doaj   +1 more source

Dissociated Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) Retains Osteoinductive Potential: An In Vivo Proxy for Burst Release. [PDF]

Cureus
Tarsitano E, Matthews CS, Riffault M, Daniel M, Anavoizat F, Adrouche S, Moal C, Odedra S, Von Benecke JP.   +8 more
europepmc   +1 more source

Sclerostin regulates bone morphogenetic protein (BMP) bioavailability through interactions with BMP complexes and fibrillin microfibrils

The FEBS Journal, EarlyView.
Sclerostin (SOST) is a multifunctional extracellular modulator of BMP and Wnt signaling. SOST binds with high affinity to fibrillin‐1 and fibrillin‐2, localizing it to fibrillin microfibrils and regulating its extracellular bioavailability. Fibrillin‐bound SOST cannot engage BMP‐7 prodomain (PD) complexes, revealing a competitive mechanism that ...
Annkatrin Correns, Fady Marcous, Steffen Lütke, Matthias Mörgelin, Philipp Barnowski, Ariane G. Furlan, Nathalie H. Schröder, Bodo Levkau, Sarah Riek, Martin Mollenhauer, Manuel Koch, Gerhard Sengle   +11 more
wiley   +1 more source